Universal precautions revisited: Managing the inherited pain patient

Pain Medicine

Volumn 10, Issue SUPPL. 2, 2009, Pages

  Gourlay, Douglas L ^a   Heit, Howard A ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inherited Pain Patient; Opioid Rotation; Universal Precautions; Urine Drug Testing

Indexed keywords

METHADONE; MORPHINE; OPIATE; OXYCODONE;

ANALGESIC ACTIVITY; CANCER PAIN; CHRONIC PAIN; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SCREENING; GENETIC VARIABILITY; HEALTH CARE PERSONNEL; HUMAN; LOW DRUG DOSE; MEDICAL DECISION MAKING; NAUSEA; OPIATE ADDICTION; OPIOID INDUCED EMESIS; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SINGLE DRUG DOSE; TREATMENT PLANNING; URINALYSIS;

ANALGESICS, OPIOID; CHRONIC DISEASE; DRUG AND NARCOTIC CONTROL; DRUG PRESCRIPTIONS; GUIDELINES AS TOPIC; HUMANS; PAIN; RISK ASSESSMENT; SPECIALTIES, MEDICAL; SUBSTANCE-RELATED DISORDERS;

EID: 68349154784     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00671.x     Document Type: Review

References (22)

1. Gourlay DL, Heit HA, Almahrezi A. Universal precautions in pain medicine: A rational approach to the management of chronic pain. Pain Med 2005;6(2):107-12.
2. Gourlay D, Heit H. Universal precautions: A matter of mutual trust and responsibility. Pain Med 2006;7(2):210-1; author reply 212.
3. American Academy of Pain Medicine, American Pain Society, American Society of Addiction Medicine. Public policy statement on the rights and responsibilities of health care professionals in the use of opioids for the treatment of pain: A consensus document from the American Academy of Pain Medicine, the American Pain Society, and the American Society of Addiction Medicine. Pain Med 2004;5(3):301-2.
4. Passik SD, Kirsh KL. Forget the recipes: Let's talk data. Pain Med 2008;9(2):261-5.
5. Li X, Clark JD. Hyperalgesia during opioid abstinence: Mediation by glutamate and substance p. Anesth Analg 2002;95(4):979-84.
6. US Food and Drug Administration. Code of Federal Regulations, Title 21, Food and Drugs. Available at: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfCFR/CFRSearch.cfm (accessed June 24, 2009).
7. Gammaitoni AR, Fine P, Alvarez N, McPherson ML, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain 2003;19(5):286-97.
8. de Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 1995;10(5):378-84.
9. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med 2003;349(20):1943-53.
10. Pasternak GW. The pharmacology of mu analgesics: From patients to genes. Neuroscientist 2001;7(3):220-31.
11. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002;18(4 suppl):S3-13.
12. Anderson R, Saiers JH, Abram S, Schlicht C. Accuracy in equianalgesic dosing. Conversion dilemmas. J Pain Symptom Manage 2001;21(5):397-406.
13. Ripamonti C, Groff L, Brunelli C, et al. Switching from morphine to oral methadone in treating cancer pain: What is the equianalgesic dose ratio? J Clin Oncol 1998;16(10):3216-21.
14. Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: Novel clinical applications with related concerns. Pain Med 2002;3(4):339-48.
15. Weschules DJ, Bain KT, Richeimer S. Actual and potential drug interactions associated with methadone. Pain Med 2008;9(3):315-44.
16. Gourlay D, Heit H. Pain and addiction: Managing risk through comprehensive care. J Addict Dis 2008;27(3):23-30.
17. Seifert CF, Kennedy S. Meperidine is alive and well in the new millennium: Evaluation of meperidine usage patterns and frequency of adverse drug reactions. Pharmacotherapy 2004;24(6):776-83.
18. Dole VP. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988;260(20):3025-9.
19. Gourlay D, Heit H, Caplan Y. Urine Drug Testing in Clinical Practice: Dispelling the Myths and Designing Strategies, 3rd edition: [Monograph for California Academy of Family Physicians]; 2006. Available at: http://www.familydocs.org/assets/Professional_Development/CME/UDT.pdf (accessed March 7, 2006).
20. Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manage 2004;27(3):260-7.
21. Passik SD, Weinreb HJ. Managing chronic nonmalignant pain: Overcoming obstacles to the use of opioids. Adv Ther 2000;17(2):70-83.
22. Weissman DE, Haddox JD. Opioid pseudoaddiction-An iatrogenic syndrome. Pain 1989;36(3):363-6.